| 0 (0%) | 05-19 03:21 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.53  |
1-year : | 3.73 |
| Resists | First : | 3.02 |
Second : | 3.2 |
| Pivot price | 2.89 |
|||
| Supports | First : | 2.74 | Second : | 2.28 |
| MAs | MA(5) : | 2.85 |
MA(20) : | 2.9 |
| MA(100) : | 3.13 |
MA(250) : | 2.34 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 30.6 |
D(3) : | 22.3 |
| RSI | RSI(14): 48.1 |
|||
| 52-week | High : | 4.18 | Low : | 1.1 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ ELUT ] has closed below upper band by 38.3%. Bollinger Bands are 63.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.99 - 3.01 | 3.01 - 3.02 |
| Low: | 2.82 - 2.83 | 2.83 - 2.85 |
| Close: | 2.91 - 2.93 | 2.93 - 2.95 |
Sun, 12 May 2024
Elutia First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St
Fri, 10 May 2024
Elutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor Fitzgerald - MarketBeat
Sun, 10 Mar 2024
Elutia Full Year 2023 Earnings: Misses Expectations - Yahoo Finance
Sun, 21 Jan 2024
Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS - Seeking Alpha
Mon, 08 Jan 2024
ELUT Stock Price and Chart — NASDAQ:ELUT — TradingView - TradingView
Tue, 02 Jan 2024
Silver Spring regenerative medicine firm Elutia regains Nasdaq compliance as business prospects brighten ... - The Business Journals
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 20 (M) |
| Shares Float | 7 (M) |
| Held by Insiders | 8.5 (%) |
| Held by Institutions | 70.2 (%) |
| Shares Short | 25 (K) |
| Shares Short P.Month | 17 (K) |
| EPS | -2.27 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.66 |
| Profit Margin | -152.2 % |
| Operating Margin | -98.7 % |
| Return on Assets (ttm) | -22.9 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -10.9 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 1.23 |
| EBITDA (p.s.) | -0.85 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -22 (M) |
| Levered Free Cash Flow | 8 (M) |
| PE Ratio | -1.3 |
| PEG Ratio | 0 |
| Price to Book value | -1.77 |
| Price to Sales | 2.37 |
| Price to Cash Flow | -2.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|